Concepts (206)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Migraine Disorders | 33 | 2024 | 1693 | 5.540 |
Why?
|
| Headache Disorders, Secondary | 11 | 2024 | 33 | 4.920 |
Why?
|
| Headache | 19 | 2024 | 1249 | 4.250 |
Why?
|
| Headache Disorders | 7 | 2024 | 148 | 2.660 |
Why?
|
| Migraine without Aura | 4 | 2022 | 82 | 2.230 |
Why?
|
| Botulinum Toxins, Type A | 4 | 2023 | 229 | 1.490 |
Why?
|
| Analgesics | 8 | 2021 | 1066 | 1.450 |
Why?
|
| Facial Pain | 2 | 2018 | 120 | 1.160 |
Why?
|
| Spiro Compounds | 1 | 2024 | 68 | 0.910 |
Why?
|
| Nonprescription Drugs | 2 | 2013 | 118 | 0.780 |
Why?
|
| Cluster Headache | 3 | 2017 | 54 | 0.730 |
Why?
|
| Oxymetazoline | 1 | 2020 | 5 | 0.710 |
Why?
|
| Tetracaine | 1 | 2020 | 34 | 0.700 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2020 | 178 | 0.650 |
Why?
|
| Amitriptyline | 2 | 2016 | 112 | 0.640 |
Why?
|
| Neuromuscular Agents | 1 | 2020 | 148 | 0.620 |
Why?
|
| Neurology | 2 | 2017 | 779 | 0.600 |
Why?
|
| Piperidines | 2 | 2024 | 1650 | 0.590 |
Why?
|
| Clinical Protocols | 2 | 2021 | 1439 | 0.590 |
Why?
|
| Pyrroles | 1 | 2024 | 1137 | 0.580 |
Why?
|
| Fellowships and Scholarships | 2 | 2017 | 1118 | 0.570 |
Why?
|
| Analgesics, Non-Narcotic | 2 | 2018 | 370 | 0.560 |
Why?
|
| Catastrophization | 2 | 2023 | 345 | 0.550 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 1 | 2018 | 170 | 0.510 |
Why?
|
| Anesthetics, Local | 2 | 2020 | 1001 | 0.490 |
Why?
|
| Pituitary Diseases | 1 | 2016 | 135 | 0.490 |
Why?
|
| Pyridines | 2 | 2024 | 2877 | 0.470 |
Why?
|
| Facial Nerve Diseases | 1 | 2014 | 49 | 0.460 |
Why?
|
| Spinal Nerves | 1 | 2014 | 91 | 0.460 |
Why?
|
| Pain Measurement | 3 | 2021 | 3514 | 0.440 |
Why?
|
| Internationality | 1 | 2019 | 1005 | 0.430 |
Why?
|
| Physicians | 3 | 2021 | 4590 | 0.430 |
Why?
|
| Drug Tolerance | 2 | 2011 | 369 | 0.420 |
Why?
|
| Patient Care | 1 | 2018 | 624 | 0.410 |
Why?
|
| Neuralgia | 1 | 2018 | 597 | 0.400 |
Why?
|
| Epidural Space | 1 | 2013 | 122 | 0.400 |
Why?
|
| Injections, Epidural | 1 | 2013 | 200 | 0.380 |
Why?
|
| Spinal Puncture | 1 | 2013 | 281 | 0.370 |
Why?
|
| Primary Prevention | 1 | 2018 | 1207 | 0.360 |
Why?
|
| Drug Therapy | 1 | 2013 | 504 | 0.360 |
Why?
|
| Quality of Life | 4 | 2024 | 13300 | 0.350 |
Why?
|
| Patient Satisfaction | 2 | 2013 | 3451 | 0.350 |
Why?
|
| Telemedicine | 4 | 2024 | 3005 | 0.340 |
Why?
|
| Guideline Adherence | 1 | 2020 | 2283 | 0.340 |
Why?
|
| Learning | 1 | 2019 | 1733 | 0.340 |
Why?
|
| Practice Guidelines as Topic | 2 | 2020 | 7468 | 0.330 |
Why?
|
| Italy | 2 | 2021 | 840 | 0.320 |
Why?
|
| Neurosurgery | 1 | 2015 | 670 | 0.310 |
Why?
|
| Humans | 66 | 2024 | 760261 | 0.310 |
Why?
|
| Philosophy | 1 | 2008 | 68 | 0.300 |
Why?
|
| Epilepsy | 2 | 2022 | 3267 | 0.290 |
Why?
|
| Catheterization | 1 | 2013 | 1432 | 0.290 |
Why?
|
| Nerve Block | 1 | 2014 | 686 | 0.290 |
Why?
|
| Tension-Type Headache | 1 | 2008 | 76 | 0.270 |
Why?
|
| Tryptamines | 2 | 2018 | 93 | 0.250 |
Why?
|
| Serotonin 5-HT1 Receptor Agonists | 2 | 2017 | 42 | 0.250 |
Why?
|
| Pain | 2 | 2023 | 5066 | 0.240 |
Why?
|
| Cost of Illness | 3 | 2020 | 1940 | 0.240 |
Why?
|
| Treatment Outcome | 10 | 2024 | 64947 | 0.230 |
Why?
|
| Pandemics | 2 | 2023 | 8621 | 0.200 |
Why?
|
| Nausea | 1 | 2024 | 677 | 0.180 |
Why?
|
| Electronic Health Records | 3 | 2018 | 4763 | 0.180 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2022 | 314 | 0.170 |
Why?
|
| Valproic Acid | 1 | 2023 | 442 | 0.170 |
Why?
|
| Constipation | 1 | 2024 | 561 | 0.160 |
Why?
|
| Serotonin Syndrome | 1 | 2018 | 18 | 0.160 |
Why?
|
| Serotonin Receptor Agonists | 1 | 2019 | 151 | 0.160 |
Why?
|
| Meditation | 1 | 2021 | 251 | 0.160 |
Why?
|
| Administration, Intranasal | 1 | 2020 | 471 | 0.150 |
Why?
|
| Bell Palsy | 1 | 2018 | 39 | 0.150 |
Why?
|
| Pain Clinics | 1 | 2016 | 51 | 0.140 |
Why?
|
| Attitude of Health Personnel | 2 | 2021 | 3870 | 0.140 |
Why?
|
| Health Care Surveys | 2 | 2020 | 2434 | 0.130 |
Why?
|
| Antidepressive Agents | 2 | 2018 | 2889 | 0.130 |
Why?
|
| Adolescent | 7 | 2022 | 87747 | 0.130 |
Why?
|
| History, 20th Century | 2 | 2015 | 2777 | 0.130 |
Why?
|
| Patient Education as Topic | 3 | 2024 | 2311 | 0.120 |
Why?
|
| Adult | 19 | 2024 | 219847 | 0.120 |
Why?
|
| RNA, Viral | 1 | 2022 | 2837 | 0.120 |
Why?
|
| Drug Combinations | 1 | 2020 | 2024 | 0.110 |
Why?
|
| False Positive Reactions | 1 | 2016 | 956 | 0.110 |
Why?
|
| Middle Aged | 14 | 2024 | 220175 | 0.110 |
Why?
|
| Censuses | 1 | 2014 | 201 | 0.110 |
Why?
|
| Benzamides | 1 | 2019 | 1369 | 0.110 |
Why?
|
| Anxiety | 4 | 2021 | 4532 | 0.110 |
Why?
|
| Face | 1 | 2018 | 1017 | 0.100 |
Why?
|
| Diagnostic Errors | 2 | 2017 | 1266 | 0.100 |
Why?
|
| Chronic Disease | 3 | 2024 | 9283 | 0.100 |
Why?
|
| Double-Blind Method | 2 | 2024 | 12412 | 0.100 |
Why?
|
| Sumatriptan | 1 | 2012 | 66 | 0.100 |
Why?
|
| Health Surveys | 2 | 2020 | 4061 | 0.100 |
Why?
|
| Feasibility Studies | 1 | 2022 | 5201 | 0.100 |
Why?
|
| Female | 21 | 2024 | 391011 | 0.090 |
Why?
|
| Bupivacaine | 1 | 2014 | 413 | 0.090 |
Why?
|
| Sternocostal Joints | 1 | 1989 | 3 | 0.090 |
Why?
|
| Sternoclavicular Joint | 1 | 1989 | 32 | 0.090 |
Why?
|
| Paratyphoid Fever | 1 | 1989 | 34 | 0.090 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2012 | 432 | 0.080 |
Why?
|
| Phytotherapy | 1 | 2012 | 295 | 0.080 |
Why?
|
| Demography | 1 | 2014 | 1650 | 0.080 |
Why?
|
| Internet | 1 | 2021 | 3074 | 0.080 |
Why?
|
| Health Status Disparities | 1 | 2020 | 1819 | 0.080 |
Why?
|
| Forecasting | 1 | 2018 | 2931 | 0.080 |
Why?
|
| History, 21st Century | 1 | 2015 | 1576 | 0.080 |
Why?
|
| Medicine | 1 | 2017 | 943 | 0.080 |
Why?
|
| Anticonvulsants | 1 | 2018 | 1881 | 0.080 |
Why?
|
| Prevalence | 4 | 2020 | 15687 | 0.080 |
Why?
|
| Patient-Centered Care | 1 | 2018 | 1416 | 0.080 |
Why?
|
| Yoga | 1 | 2012 | 281 | 0.070 |
Why?
|
| Male | 16 | 2024 | 359413 | 0.070 |
Why?
|
| Young Adult | 4 | 2020 | 58673 | 0.070 |
Why?
|
| Happiness | 1 | 2008 | 170 | 0.070 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 1989 | 286 | 0.070 |
Why?
|
| Craniopharyngioma | 1 | 1989 | 277 | 0.070 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 14656 | 0.070 |
Why?
|
| Population Surveillance | 1 | 2017 | 2609 | 0.070 |
Why?
|
| Program Evaluation | 1 | 2014 | 2494 | 0.070 |
Why?
|
| Academic Medical Centers | 1 | 2016 | 2753 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 1 | 2022 | 9196 | 0.060 |
Why?
|
| Clinical Trials as Topic | 2 | 2011 | 8058 | 0.060 |
Why?
|
| Secondary Prevention | 1 | 2011 | 1548 | 0.060 |
Why?
|
| Pilot Projects | 3 | 2024 | 8553 | 0.060 |
Why?
|
| Diagnosis, Differential | 2 | 2018 | 12968 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 10829 | 0.060 |
Why?
|
| Child | 3 | 2022 | 79758 | 0.060 |
Why?
|
| Registries | 2 | 2017 | 8449 | 0.050 |
Why?
|
| Menstrual Cycle | 1 | 2007 | 536 | 0.050 |
Why?
|
| Longitudinal Studies | 2 | 2018 | 14482 | 0.050 |
Why?
|
| Boston | 1 | 2016 | 9282 | 0.050 |
Why?
|
| Pharmaceutical Preparations | 1 | 2011 | 1093 | 0.050 |
Why?
|
| United States | 5 | 2021 | 72363 | 0.050 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 2282 | 0.050 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2008 | 1256 | 0.050 |
Why?
|
| Osteoarthritis | 1 | 1989 | 1055 | 0.050 |
Why?
|
| Curriculum | 1 | 2014 | 3722 | 0.050 |
Why?
|
| Tuberculosis, Lymph Node | 1 | 1980 | 21 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2016 | 8018 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 39254 | 0.040 |
Why?
|
| Ultrasonography | 2 | 2013 | 5960 | 0.040 |
Why?
|
| Estrogens | 1 | 2007 | 1520 | 0.040 |
Why?
|
| Drug Delivery Systems | 1 | 2011 | 2218 | 0.040 |
Why?
|
| Counseling | 1 | 2008 | 1550 | 0.040 |
Why?
|
| Time Factors | 2 | 2019 | 40133 | 0.040 |
Why?
|
| Menopause | 1 | 2007 | 1640 | 0.040 |
Why?
|
| Aged | 5 | 2019 | 168995 | 0.040 |
Why?
|
| Hyperalgesia | 1 | 2023 | 530 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 20048 | 0.040 |
Why?
|
| Mediastinal Neoplasms | 1 | 1980 | 402 | 0.040 |
Why?
|
| Vertigo | 1 | 2019 | 202 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2017 | 41317 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2012 | 3762 | 0.030 |
Why?
|
| Life Style | 1 | 2008 | 3888 | 0.030 |
Why?
|
| Radicular Cyst | 1 | 1995 | 12 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2006 | 4286 | 0.030 |
Why?
|
| Prescriptions | 1 | 2018 | 388 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2008 | 3598 | 0.030 |
Why?
|
| Disease Progression | 1 | 2011 | 13505 | 0.030 |
Why?
|
| Maxillary Sinus | 1 | 1995 | 180 | 0.030 |
Why?
|
| Diet | 1 | 2012 | 8008 | 0.030 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2018 | 623 | 0.030 |
Why?
|
| Fatigue | 1 | 2019 | 1544 | 0.020 |
Why?
|
| Social Behavior | 1 | 2018 | 1130 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2019 | 4044 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 2018 | 2656 | 0.020 |
Why?
|
| Salmonella paratyphi A | 1 | 1989 | 47 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2018 | 80301 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2021 | 3903 | 0.020 |
Why?
|
| Joints | 1 | 1989 | 321 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2018 | 2958 | 0.020 |
Why?
|
| Prognosis | 1 | 2008 | 29636 | 0.020 |
Why?
|
| Phytoestrogens | 1 | 2007 | 59 | 0.020 |
Why?
|
| Shoulder | 1 | 1988 | 299 | 0.020 |
Why?
|
| Recurrence | 1 | 2018 | 8487 | 0.020 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2007 | 190 | 0.020 |
Why?
|
| Retreatment | 1 | 2007 | 600 | 0.020 |
Why?
|
| Television | 1 | 1988 | 409 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2006 | 17766 | 0.010 |
Why?
|
| Depression | 2 | 2018 | 8033 | 0.010 |
Why?
|
| Cysts | 1 | 1989 | 683 | 0.010 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2007 | 404 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2023 | 7809 | 0.010 |
Why?
|
| Comorbidity | 1 | 2017 | 10552 | 0.010 |
Why?
|
| Ovary | 1 | 2007 | 959 | 0.010 |
Why?
|
| Electric Stimulation Therapy | 1 | 2007 | 613 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2007 | 2646 | 0.010 |
Why?
|
| Calcinosis | 1 | 1989 | 1478 | 0.010 |
Why?
|
| Risk Factors | 1 | 2008 | 74269 | 0.010 |
Why?
|
| Smoking | 1 | 2017 | 9070 | 0.010 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2007 | 1207 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 3 | 1995 | 20484 | 0.010 |
Why?
|
| Mental Disorders | 1 | 2017 | 6797 | 0.010 |
Why?
|
| Neurosurgical Procedures | 1 | 2007 | 2056 | 0.010 |
Why?
|
| Maxillary Sinusitis | 1 | 1995 | 41 | 0.010 |
Why?
|
| Drainage | 1 | 1980 | 1161 | 0.010 |
Why?
|
| Reference Values | 1 | 1981 | 4920 | 0.010 |
Why?
|
| Animals | 1 | 2006 | 167940 | 0.010 |
Why?
|
| Antitubercular Agents | 1 | 1980 | 1374 | 0.010 |
Why?
|
| Multiple Myeloma | 1 | 1989 | 5131 | 0.010 |
Why?
|
| Plasmacytoma | 1 | 1989 | 171 | 0.000 |
Why?
|
| Sex Factors | 1 | 1981 | 10530 | 0.000 |
Why?
|
| Hypertension | 1 | 2008 | 8595 | 0.000 |
Why?
|
| Radiography | 2 | 1989 | 6965 | 0.000 |
Why?
|
| Electroencephalography | 1 | 1981 | 6182 | 0.000 |
Why?
|
| Age Factors | 1 | 1981 | 18415 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1989 | 36247 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 1989 | 21065 | 0.000 |
Why?
|
Concepts
(206)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(9)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_